Scarica l'app Stockscreener
5.98
0.34%
0.02
Precedente Chiudi:
$5.96
Aprire:
$5.91
Volume 24 ore:
56,401
Relative Volume:
0.81
Capitalizzazione di mercato:
$130.02M
Reddito:
$10.22M
Utile/perdita netta:
$-20.67M
Rapporto P/E:
-5.1107
EPS:
-1.1701
Flusso di cassa netto:
$-16.02M
1 W Prestazione:
+11.99%
1M Prestazione:
+3.10%
6M Prestazione:
-19.62%
1 anno Prestazione:
+17.72%
Intervallo 1D:
$5.90
$6.41
Intervallo di 1 settimana:
$4.87
$6.41
Portata 52W:
$3.75
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Nome
Alpha Cognition Inc
Settore
Industria
Telefono
(858) 344-4375
Indirizzo
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
5.98 | 130.02M | 10.22M | -20.67M | -16.02M | -1.1701 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Iniziato | H.C. Wainwright | Buy |
Alpha Cognition Inc Borsa (ACOG) Ultime notizie
Alpha Cognition Earnings Call: Early Traction, Rising Costs - TipRanks
Alpha Cognition Inc. (ACOG) soars 8.6%: Is further upside left in the stock? - MSN
Alpha Cognition Inc (OTC:ACOGF) Stock Quote - The Chronicle-Journal
Movement Recap: Can Alpha Cognition Inc stock double in the next yearMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Alpha Cognition (NASDAQ:ACOG) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Alpha Cognition Inc. (ACOG) Jumps 8.6%: Does the Stock Have More Room to Grow? - Bitget
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury - BioSpace
Opaleye Management Inc. Increases Stake in Alpha Cognition Inc. - GuruFocus
Alpha Cognition receives U.S. patent for traumatic brain injury drug By Investing.com - Investing.com Australia
Alpha Cognition receives issued U.S. patent for Alpha-1062 for treatment of traumatic brain injury - marketscreener.com
Alpha Cognition receives U.S. patent for traumatic brain injury drug - Investing.com
Alpha Cognition Reports Strong ZUNVEYL Adoption in Long-Term Care Facilities - citybuzz -
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 - nasdaq.com
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript - The Globe and Mail
EV Market: Will Alpha Cognition Inc benefit from geopolitical trendsQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Alpha Cognition (NASDAQ: ACOG) outlines ZUNVEYL launch, $44M license and Alzheimer’s pipeline - stocktitan.net
Opaleye fund adds Alpha Cognition (ACOG) stake with new share purchases - stocktitan.net
Aug PreEarnings: Does Alpha Cognition Inc have declining or rising EPS2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Major Investor Doubles Down on Alpha Cognition With Fresh Capital Infusion - TipRanks
Can Alpha Cognition Inc outperform under higher oil prices2026 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Alpha Cognition Reports Q4 Earnings, Highlights Continued ZUNVEYL Growth - National Today
Alpha Cognition (NASDAQ:ACOG) Posts Earnings Results, Misses Estimates By $0.03 EPS - marketbeat.com
Alpha Cognition Inc. Announces 2026 Annual General Meeting Date and Details for Security Holders - Minichart
Alpha Cognition Q4 Earnings Call Highlights - Defense World
Alpha Cognition schedules annual shareholder meeting for June 16 By Investing.com - Investing.com Australia
Alpha Cognition schedules annual shareholder meeting for June 16 - uk.investing.com
Alpha Cognition (NASDAQ: ACOG) sets June 16, 2026 annual shareholder meeting - Stock Titan
Alpha Cognition Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
Alpha Cognition reports Q4 revenue of $2.5M for Alzheimer’s drug - Investing.com Australia
Major Investor Quietly Boosts Stake in Alpha Cognition Inc. - TipRanks
Alpha Cognition Q4 2025 Earnings Call Transcript - MarketBeat
Alpha Cognition Inc. (ACOG) reports Q4 loss, lags revenue estimates - MSN
[Form 4] Alpha Cognition Inc. Insider Trading Activity - Stock Titan
Earnings call transcript: Alpha Cognition Q4 2025 earnings call highlights growth By Investing.com - Investing.com Australia
Alpha Cognition Inc. (ACOG) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
ACOG: Q4 2025 saw rapid ZUNVEYL adoption, strong sales, and expanded payer access, supporting future growth - TradingView
Earnings call transcript: Alpha Cognition Q4 2025 earnings call highlights growth - Investing.com
Alpha Cognition Inc. (ACOG) Reports Q4 Loss, Lags Revenue Estimates - finance.yahoo.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Alpha Cognition reports Q4 revenue of $2.5M for Alzheimer’s drug By Investing.com - Investing.com South Africa
Alpha Cognition reports $10.2M revenue in FY2025, $6.8M product sales; $20.7M net loss - TradingView
ALPHA COGNITION ($ACOG) Releases Q4 2025 Earnings - Quiver Quantitative
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update - Business Wire
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Volume: Will Alpha Cognition Inc outperform during market ralliesNew Guidance & Long-Term Investment Growth Plans - baoquankhu1.vn
Earnings Scheduled For March 26, 2026 - Benzinga
Alpha Cognition Inc Azioni (ACOG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):